Mei Lin Selected Research

netoglitazone

4/2009	High-throughput quantification of a novel thiazolidinedione MCC-555 in rat plasma by ultra-fast liquid chromatography and its application in pharmacokinetic studies.
3/2009	Subchronic toxicity and toxicokinetics of MCC-555, a novel thiazolidinedione, after 270-day repeated oral administration in dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei Lin Research Topics

Disease

37	Neoplasms (Cancer) 01/2022 - 12/2003
12	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2012
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2013
8	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 05/2012
8	Nasopharyngeal Carcinoma 11/2021 - 01/2018
8	Type 2 Diabetes Mellitus (MODY) 08/2021 - 03/2009
8	Oral Lichen Planus 05/2014 - 03/2005
7	Carcinoma (Carcinomatosis) 05/2022 - 12/2003
7	Hyperthermia 01/2022 - 02/2013
7	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 08/2005
7	Pain (Aches) 03/2012 - 03/2003
5	Lymphatic Metastasis 01/2021 - 12/2003
5	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 12/2003
5	Carcinogenesis 01/2020 - 12/2003
4	Inflammation (Inflammations) 11/2021 - 03/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2016
4	Esophageal Squamous Cell Carcinoma 09/2018 - 10/2012
4	Insulin Resistance 10/2016 - 04/2009
4	Ulcer 03/2012 - 02/2008
4	Burning Mouth Syndrome (Syndrome, Burning Mouth) 01/2007 - 03/2003
3	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2017
3	Periodontitis 01/2020 - 01/2019
3	Leukemia 08/2018 - 02/2007
3	Aphthous Stomatitis (Aphthous Ulcer) 05/2009 - 10/2006
2	Circulating Neoplastic Cells 05/2022 - 11/2019
2	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 01/2022
2	Mucositis 11/2021 - 01/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2021 - 05/2016
2	Diarrhea 08/2021 - 01/2018
2	Vomiting 08/2021 - 03/2009
2	Hypoxia (Hypoxemia) 01/2020 - 01/2015
2	Dental Caries (Decay, Dental) 02/2019 - 01/2018
2	Alveolar Bone Loss 01/2019 - 08/2017
2	Necrosis 12/2018 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 03/2018 - 07/2013
2	Infections 08/2017 - 08/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 09/2013
2	Oral Candidiasis (Thrush) 01/2016 - 03/2014
2	Encephalitis (Encephalitis, Rasmussen) 01/2015 - 01/2014
2	Meningitis 01/2015 - 01/2014
2	Vascular Remodeling 08/2014 - 01/2014
2	Pulmonary Arterial Hypertension 08/2014 - 01/2014
2	Typhoid Fever (Typhoid) 08/2014 - 09/2010

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2022 - 07/2007
7	Long Noncoding RNAIBA 03/2021 - 06/2016
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2009
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 08/2014
6	Therapeutic UsesIBA 01/2022 - 03/2005
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2013
5	Insulin (Novolin)FDA Link 08/2021 - 01/2005
5	CytokinesIBA 01/2019 - 02/2008
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 12/2003
4	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 09/2006
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2012
3	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2016
3	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2011
3	EnzymesIBA 01/2020 - 08/2006
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 07/2009
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2018 - 10/2016
3	Fish OilsIBA 05/2018 - 02/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2016 - 04/2009
3	TabletsIBA 01/2016 - 10/2006
2	Epidermal Growth Factor (EGF)IBA 05/2022 - 02/2008
2	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2018
2	Metformin (Glucophage)FDA LinkGeneric 08/2021 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 08/2021 - 01/2017
2	Ointments (Pastes)IBA 02/2021 - 05/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 06/2013
2	Dosage Forms (Dosage Form)IBA 01/2021 - 05/2009
2	Peptides (Polypeptides)IBA 01/2021 - 01/2017
2	InterferonsIBA 01/2021 - 12/2011
2	ParaffinIBA 04/2020 - 03/2010
2	Messenger RNA (mRNA)IBA 04/2020 - 08/2006
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2020 - 02/2019
2	Photosensitizing Agents (Photosensitizers)IBA 01/2020 - 01/2020
2	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 01/2020 - 11/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 01/2020
2	InterleukinsIBA 01/2019 - 04/2012
2	Linseed Oil (Flaxseed Oil)IBA 05/2018 - 10/2016
2	Biological ProductsIBA 03/2018 - 12/2003
2	Cetuximab (Erbitux)FDA Link 01/2018 - 01/2015
2	Cyclin D1IBA 01/2017 - 01/2015
2	Indicators and Reagents (Reagents)IBA 01/2017 - 04/2012
2	AlbuminsIBA 01/2016 - 01/2015
2	Bortezomib (Velcade)FDA Link 08/2014 - 01/2014
2	Betamethasone (Celestone)FDA Link 05/2014 - 11/2013
2	ferriteIBA 01/2014 - 06/2013
2	Polysaccharides (Glycans)IBA 02/2013 - 05/2007
2	Vascular Endothelial Growth Factor CIBA 10/2012 - 03/2011

Therapy/Procedure

19	Therapeutics 03/2022 - 03/2003
7	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
6	Radiotherapy 01/2021 - 06/2013
6	Aftercare (After-Treatment) 01/2018 - 03/2003
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2020
3	Induction Chemotherapy 10/2021 - 01/2018
3	Nanospheres 01/2018 - 01/2015
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2021 - 11/2019
2	Chemoradiotherapy 01/2019 - 01/2018